Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

News

May 3, 2010 – Excellent safety and clinical outcomes were shown in patients ages 70 and older who received a ...

Home May 03, 2010
Home
An illustration showing how the Amphirion_drug-eluting, drug-coated balloon technology works.
Feature | Drug-Eluting Balloons | Dave Fornell


Drug-eluting balloons (DEBs) may offer new options in treating peripheral vessels and restenosis. DEBs already ...

Home May 03, 2010
Home
News

April 27, 2010 – New findings confirm atrial fibrillation (AF) is independently associated with the risk of all ...

Home April 27, 2010
Home
News

April 19, 2010 — The latest research in a series of studies at The Children’s Hospital of Philadelphia ...

Home April 26, 2010
Home
News

April 21, 2010 — A landmark clinical trial has begun in Europe to explore the safety and efficacy of a ...

Home April 26, 2010
Home
News

April 21, 2010 – More than 100,000 amputations are performed each year in the United States on patients with ...

Home April 21, 2010
Home
News

April 21, 2010 – The growing number of Americans with cardiovascular disease has caused a heightened sensitivity ...

Home April 21, 2010
Home
News

April 13, 2010 – More than 300 patients in Europe have been enrolled in a real-world study to assess the ...

Home April 13, 2010
Home
Feature

April 13, 2010 – Obstructive sleep apnea is associated with an increased risk of stroke in middle-aged and older ...

Home April 13, 2010
Home
News

April 9, 2010 – A preclinical study shows the action of a toll-like receptor (TLR) antagonist helps reduce ...

Home April 08, 2010
Home
News

April 5, 2010 – Patient enrollment was recently completed in the Small Vessel and Long Lesion trials of the ...

Home April 05, 2010
Home
News

March 30, 2010 – The FDA granted an investigational device exemption (IDE) for a clinical study of the Freedom ...

Home March 30, 2010
Home
News

March 26, 2010 – Nearly 14 percent of Medicare beneficiaries admitted with a primary diagnosis of ST-elevated ...

Home March 26, 2010
Home
News

March 25, 2010 – The FDA this week granted permission for a conditional investigational device exemption (IDE) to ...

Home March 25, 2010
Home
Feature | Dave Fornell

Final five-year results from the ENDEAVOR III trial, comparing the Endeavor Zotarolimus-Eluting Coronary Stent to ...

Home March 24, 2010
Home
Subscribe Now